Hutch News

Hutch News

Stories tagged 'biomarkers'

Artificial intelligence and cancer

New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations

May 6, 2019 | By Diane Mapes / Fred Hutch News Service

Researchers at Fred Hutch are using a type of artificial intelligence called natural language processing, or NLP, to delve into the pathology reports of metastatic non-small cell lung cancer patients to find if they have two treatable mutations. Dr. Bernardo Goulart tells us why.

View story >


Washington’s Andy Hill Cancer Research Endowment awards $1.5M to 3 Fred Hutch researchers

Scientists will use funds to expand research in graft-vs.-host disease, chemoprevention and cancer immunology

Sept. 14, 2018 | By Jill Christensen / Fred Hutch News Service

Three Fred Hutch researchers recently were awarded a total of $1.5 million from the Andy Hill Cancer Research Endowment, a public-private partnership that supports cancer research in Washington.

View story >


H. pylori test hints at risk factor for stomach cancer

Pilot study suggests specific strain of bacteria may be found more often in East Asian patients with stomach cancer

Sept. 12, 2018 | By Sabrina Richards / Fred Hutch News Service

A pilot study by Dr. Nina Salama at Fred Hutch hints that carrying a specific strain of H. pylori could be a risk factor for stomach cancer in East Asian patients.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.